These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36916944)

  • 41. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
    Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR
    Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.
    Chappell CA; Lamorde M; Nakalema S; Chen BA; Mackline H; Riddler SA; Cohn SE; Darin KM; Achilles SL; Scarsi KK
    AIDS; 2017 Sep; 31(14):1965-1972. PubMed ID: 28692531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of malaria-induced alteration of metabolism on piperaquine disposition in Plasmodium yoelii infected mice and predicted in malaria patients.
    Xie Y; Zhang Y; Lin F; Chen X; Xing J
    Int J Antimicrob Agents; 2024 Jul; 64(1):107209. PubMed ID: 38761871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.
    Zang M; Zhu F; Zhao L; Yang A; Li X; Liu H; Xing J
    Malar J; 2014 Dec; 13():478. PubMed ID: 25476790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women.
    Natureeba P; Ades V; Luwedde F; Mwesigwa J; Plenty A; Okong P; Charlebois ED; Clark TD; Nzarubara B; Havlir DV; Achan J; Kamya MR; Cohan D; Dorsey G
    J Infect Dis; 2014 Dec; 210(12):1938-45. PubMed ID: 24958908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.
    Zorrilla CD; Wright R; Osiyemi OO; Yasin S; Baugh B; Brown K; Coate B; Verboven P; Mrus J; Falcon R; Kakuda TN
    HIV Med; 2014 Jan; 15(1):50-6. PubMed ID: 23731450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.
    Moore BR; Batty KT; Andrzejewski C; Jago JD; Page-Sharp M; Ilett KF
    Antimicrob Agents Chemother; 2008 Jan; 52(1):306-11. PubMed ID: 17984231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children.
    Chotsiri P; Zongo I; Milligan P; Compaore YD; Somé AF; Chandramohan D; Hanpithakpong W; Nosten F; Greenwood B; Rosenthal PJ; White NJ; Ouédraogo JB; Tarning J
    Nat Commun; 2019 Jan; 10(1):480. PubMed ID: 30696903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project).
    González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Pons-Duran C; Dimessa LB; Lell B; Lagler H; Garcia-Otero L; Zoleko Manego R; El Gaaloul M; Sanz S; Piqueras M; Sevene E; Ramharter M; Saute F; Menendez C
    BMJ Open; 2021 Nov; 11(11):e053197. PubMed ID: 34815285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
    Fernandes S; Were V; Gutman J; Dorsey G; Kakuru A; Desai M; Kariuki S; Kamya MR; Ter Kuile FO; Hanson K
    Lancet Glob Health; 2020 Dec; 8(12):e1512-e1523. PubMed ID: 33137287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
    Bergstrand M; Nosten F; Lwin KM; Karlsson MO; White NJ; Tarning J
    Sci Transl Med; 2014 Oct; 6(260):260ra147. PubMed ID: 25355697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.
    Huang L; Parikh S; Rosenthal PJ; Lizak P; Marzan F; Dorsey G; Havlir D; Aweeka FT
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):310-6. PubMed ID: 22918158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.
    Koss CA; Natureeba P; Plenty A; Luwedde F; Mwesigwa J; Ades V; Charlebois ED; Clark TD; Achan J; Ruel T; Nzarubara B; Kamya MR; Havlir DV; Cohan D
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):128-35. PubMed ID: 25072616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
    Natureeba P; Kakuru A; Muhindo M; Ochieng T; Ategeka J; Koss CA; Plenty A; Charlebois ED; Clark TD; Nzarubara B; Nakalembe M; Cohan D; Rizzuto G; Muehlenbachs A; Ruel T; Jagannathan P; Havlir DV; Kamya MR; Dorsey G
    J Infect Dis; 2017 Jul; 216(1):29-35. PubMed ID: 28329368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.
    Karunajeewa HA; Ilett KF; Mueller I; Siba P; Law I; Page-Sharp M; Lin E; Lammey J; Batty KT; Davis TM
    Antimicrob Agents Chemother; 2008 Jan; 52(1):237-43. PubMed ID: 17967917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
    Kakuru A; Jagannathan P; Muhindo MK; Natureeba P; Awori P; Nakalembe M; Opira B; Olwoch P; Ategeka J; Nayebare P; Clark TD; Feeney ME; Charlebois ED; Rizzuto G; Muehlenbachs A; Havlir DV; Kamya MR; Dorsey G
    N Engl J Med; 2016 Mar; 374(10):928-39. PubMed ID: 26962728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.
    McDonald CR; Conroy AL; Gamble JL; Papp E; Hawkes M; Olwoch P; Natureeba P; Kamya M; Silverman M; Cohan D; Koss CA; Dorsey G; Kain KC; Serghides L
    Clin Infect Dis; 2018 Jan; 66(3):428-436. PubMed ID: 29136115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Hill J; Ouma P; Oluoch S; Bruce J; Kariuki S; Desai M; Webster J
    Malar J; 2020 Nov; 19(1):433. PubMed ID: 33238999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.
    Maganda BA; Minzi OM; Kamuhabwa AA; Ngasala B; Sasi PG
    Malar J; 2014 May; 13():205. PubMed ID: 24885714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
    Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
    BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.